FII Holdings

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE5977.2523.15 (+0.39 %)
PREV CLOSE ( ) 5954.10
OPEN PRICE ( ) 5960.00
BID PRICE (QTY) 5973.15 (2)
OFFER PRICE (QTY) 5976.70 (1)
VOLUME 5019
TODAY'S LOW / HIGH ( )5923.00 5991.35
52 WK LOW / HIGH ( )4383.4 6505.5
NSE5972.1520.05 (+0.34 %)
PREV CLOSE( ) 5952.10
OPEN PRICE ( ) 5960.05
BID PRICE (QTY) 5970.50 (8)
OFFER PRICE (QTY) 5972.15 (7)
VOLUME 186557
TODAY'S LOW / HIGH( ) 5921.05 5994.85
52 WK LOW / HIGH ( )4384.05 6505.9
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.